Table 2.

Effects of BCACs on Serum Levels of NO in Patients with OAG (BCACs, n=19 and Placebo Groups, n=19)

	[NO2−] (μmol/L)
Group	0 M	6 M	12 M	18 M	24 M
BCACs	7.50±2.66	7.49±5.18	7.59±7.14	7.15±1.82	7.42±3.64
Placebo	7.56±2.10	7.86±1.68	7.84±4.34	7.56±3.22	7.40±3.74
	[NO2− + NO3−] (μmol/L)
BCACs	15.84±9.92	15.47±5.12	15.09±7.36	15.84±14.56	15.45±5.92
Placebo	15.50±12.64	15.40±3.36	16.00±10.08	15.94±4.80	15.52±12.96

Values shown are mean±SD.

No statistical differences between groups (2-way repeated measures ANOVA) and intergroups (paired t-test) were observed.